Cargando…

Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy

Activation of the nerve growth factor (NGF) signaling pathway is a potential method of treatment for retinal ganglion cell (RGC) loss due to traumatic optic neuropathy (TON). The present study aimed to explore the biological effects of injecting Astragalus membranaceus (A. mem) on RGCs in an experim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qiong, Gu, Xinyi, Liu, Xinyan, Yan, Xiaoling, Liao, Liang, Zhou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762646/
https://www.ncbi.nlm.nih.gov/pubmed/33381196
http://dx.doi.org/10.1155/2020/2429843
_version_ 1783627855259762688
author Wu, Qiong
Gu, Xinyi
Liu, Xinyan
Yan, Xiaoling
Liao, Liang
Zhou, Jian
author_facet Wu, Qiong
Gu, Xinyi
Liu, Xinyan
Yan, Xiaoling
Liao, Liang
Zhou, Jian
author_sort Wu, Qiong
collection PubMed
description Activation of the nerve growth factor (NGF) signaling pathway is a potential method of treatment for retinal ganglion cell (RGC) loss due to traumatic optic neuropathy (TON). The present study aimed to explore the biological effects of injecting Astragalus membranaceus (A. mem) on RGCs in an experimental TON model. Adult male Wistar rats were randomly divided into three groups: sham-operated (SL), model (ML), and A. mem injection (AL). The left eyes of the rats were considered the experimental eyes, and the right eyes served as the controls. AL rats received daily intraperitoneal injections of A. mem (3 mL/kg), whereas ML and SL rats were administered the same volume of normal saline. The TON rat model was induced by optic nerve (ON) transverse quantitative traction. After two-week administration, the number of RGCs was determined using retrograde labeling with Fluoro-Gold. The protein levels of NGF, tyrosine kinase receptor A (TrkA), c-Jun N-terminal protein kinase (JNK), JNK phosphorylation (p-JNK), and nuclear factor kappa-B (NF-κB) were assessed using western blotting. The levels of p75 neurotrophin receptor (p75(NTR)) and NF-κB DNA binding were examined using real-time PCR and an electrophoretic mobility shift assay. In addition, the concentrations of JNK and p-JNK were assessed using an enzyme-linked immunosorbent assay. Results. The number of RGCs in ML was found to be significantly decreased (P < 0.01) relative to both AL and SL, together with the downregulation of NGF (P < 0.01), TrkA (P < 0.05), and NF-κB (P < 0.01); upregulation of p75(NTR) mRNA (P < 0.01); and increased protein levels of JNK (P < 0.05) and p-JNK (P < 0.05). Treatment using A. mem injection significantly preserved the density of RGCs in rats with experimental TON and markedly upregulated the proteins of NGF (P < 0.01), TrkA (P < 0.05), and NF-κB (P < 0.01) and downregulated the mRNA level of p75(NTR)(P < 0.01), as well as the proteins of JNK (P < 0.05) and p-JNK (P < 0.01). Thus, A. mem injection could reduce RGC death in TON induced by ON transverse quantitative traction by stimulating the NGF signaling pathway.
format Online
Article
Text
id pubmed-7762646
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-77626462020-12-29 Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy Wu, Qiong Gu, Xinyi Liu, Xinyan Yan, Xiaoling Liao, Liang Zhou, Jian Evid Based Complement Alternat Med Research Article Activation of the nerve growth factor (NGF) signaling pathway is a potential method of treatment for retinal ganglion cell (RGC) loss due to traumatic optic neuropathy (TON). The present study aimed to explore the biological effects of injecting Astragalus membranaceus (A. mem) on RGCs in an experimental TON model. Adult male Wistar rats were randomly divided into three groups: sham-operated (SL), model (ML), and A. mem injection (AL). The left eyes of the rats were considered the experimental eyes, and the right eyes served as the controls. AL rats received daily intraperitoneal injections of A. mem (3 mL/kg), whereas ML and SL rats were administered the same volume of normal saline. The TON rat model was induced by optic nerve (ON) transverse quantitative traction. After two-week administration, the number of RGCs was determined using retrograde labeling with Fluoro-Gold. The protein levels of NGF, tyrosine kinase receptor A (TrkA), c-Jun N-terminal protein kinase (JNK), JNK phosphorylation (p-JNK), and nuclear factor kappa-B (NF-κB) were assessed using western blotting. The levels of p75 neurotrophin receptor (p75(NTR)) and NF-κB DNA binding were examined using real-time PCR and an electrophoretic mobility shift assay. In addition, the concentrations of JNK and p-JNK were assessed using an enzyme-linked immunosorbent assay. Results. The number of RGCs in ML was found to be significantly decreased (P < 0.01) relative to both AL and SL, together with the downregulation of NGF (P < 0.01), TrkA (P < 0.05), and NF-κB (P < 0.01); upregulation of p75(NTR) mRNA (P < 0.01); and increased protein levels of JNK (P < 0.05) and p-JNK (P < 0.05). Treatment using A. mem injection significantly preserved the density of RGCs in rats with experimental TON and markedly upregulated the proteins of NGF (P < 0.01), TrkA (P < 0.05), and NF-κB (P < 0.01) and downregulated the mRNA level of p75(NTR)(P < 0.01), as well as the proteins of JNK (P < 0.05) and p-JNK (P < 0.01). Thus, A. mem injection could reduce RGC death in TON induced by ON transverse quantitative traction by stimulating the NGF signaling pathway. Hindawi 2020-12-18 /pmc/articles/PMC7762646/ /pubmed/33381196 http://dx.doi.org/10.1155/2020/2429843 Text en Copyright © 2020 Qiong Wu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wu, Qiong
Gu, Xinyi
Liu, Xinyan
Yan, Xiaoling
Liao, Liang
Zhou, Jian
Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy
title Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy
title_full Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy
title_fullStr Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy
title_full_unstemmed Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy
title_short Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy
title_sort astragalus membranaceus injection protects retinal ganglion cells by regulating the nerve growth factor signaling pathway in experimental rat traumatic optic neuropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762646/
https://www.ncbi.nlm.nih.gov/pubmed/33381196
http://dx.doi.org/10.1155/2020/2429843
work_keys_str_mv AT wuqiong astragalusmembranaceusinjectionprotectsretinalganglioncellsbyregulatingthenervegrowthfactorsignalingpathwayinexperimentalrattraumaticopticneuropathy
AT guxinyi astragalusmembranaceusinjectionprotectsretinalganglioncellsbyregulatingthenervegrowthfactorsignalingpathwayinexperimentalrattraumaticopticneuropathy
AT liuxinyan astragalusmembranaceusinjectionprotectsretinalganglioncellsbyregulatingthenervegrowthfactorsignalingpathwayinexperimentalrattraumaticopticneuropathy
AT yanxiaoling astragalusmembranaceusinjectionprotectsretinalganglioncellsbyregulatingthenervegrowthfactorsignalingpathwayinexperimentalrattraumaticopticneuropathy
AT liaoliang astragalusmembranaceusinjectionprotectsretinalganglioncellsbyregulatingthenervegrowthfactorsignalingpathwayinexperimentalrattraumaticopticneuropathy
AT zhoujian astragalusmembranaceusinjectionprotectsretinalganglioncellsbyregulatingthenervegrowthfactorsignalingpathwayinexperimentalrattraumaticopticneuropathy